文献速递慢性静脉疾病

小隐静脉功能不全治疗方式解剖学成功率的系统综述与网络Meta分析

Anatomic Success of Treatment Modalities for Small Saphenous Vein Incompetence: A Systematic Review and Network Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-05-29

网络Meta分析显示短期的EVLA和中期的RFA排名最优,Meta分析报告RFA短期解剖学成功率为98.4%,EVLA中期和长期分别为96.1%和94.3%。深静脉血栓发生率为0.2%,神经损伤为3.0%。

要点

  • 网络Meta分析显示短期EVLA排名最优,中期RFA排名最优。
  • Meta分析报告RFA短期解剖学成功率98.4%,EVLA中期96.1%、长期94.3%。
  • 深静脉血栓发生率0.2%,神经损伤发生率3.0%。

核心结论

  • 关于SSV的高质量比较研究有限,难以基于解剖学成功率为各治疗方式排序。
  • RFA和EVLA显示出最高的解剖学成功率。

研究设计与样本

  • 系统综述与网络Meta分析,检索MEDLINE和Embase数据库。
  • 纳入队列研究(前瞻性和回顾性)及随机对照试验。
  • 解剖学成功定义为闭塞或无返流,评估短期(≤3个月)、中期(3个月至1年)和长期(>1年)随访。
  • 进行了偏倚风险评价和GRADE评价。

主要发现

  • 网络Meta分析将EVLA排名为短期随访的最优治疗,RFA排名为中期随访的最优治疗。
  • 长期结局数据不足,无法进行网络Meta分析。
  • Meta分析报告RFA短期随访解剖学成功率最高(98.4%),EVLA中期和长期随访解剖学成功率最高(分别为96.1%和94.3%)。
  • 次要结局中仅主要并发症可合并分析:深静脉血栓发生率为0.2%,神经损伤发生率为3.0%。
  • 网络Meta分析偏倚风险低,但大多数网络估计的GRADE质量为低或极低。

临床怎么用

  • RFA和EVLA在小隐静脉功能不全的治疗中显示出最高的解剖学成功率。
  • 由于高质量比较研究有限,基于解剖学成功率的治疗排序受到限制。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High quality comparative studies on treatments of the small saphenous vein (SSV) are lacking. Therefore, the primary aim of this study was to evaluate anatomic success across different SSV treatment modalities at short, mid, and long term follow up using a network meta-analysis (NMA) and pooled results from a meta-analysis. DATA SOURCES: MEDLINE and Embase. REVIEW METHODS: Cohort studies (prospective and retrospective) and randomised controlled trials (RCTs) were included. Studies reported on the primary outcome of anatomic success (occlusion, absence of reflux) for all thermal, non-thermal, and surgical SSV treatment modalities. Secondary outcomes included complications, peri-procedural pain, time to return to daily activities or work, Venous Clinical Severity Score, and quality of life. Anatomic success was assessed at short term (up to and including three months), midterm (three months to one year), and long term (more than one year) follow up. A risk of bias and Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evaluation were done. RESULTS: Sixty eight articles were included (28 retrospective studies, 26 prospective studies, four RCTs, and nine studies of unknown design), comprising a total of 6 793 limbs at baseline. The NMA ranked endovenous laser ablation (EVLA) as superior treatment at short term follow up, and radiofrequency ablation (RFA) at midterm follow up. Data were insufficient to perform a NMA for long term outcomes. The meta-analysis reported the highest anatomic success rates for RFA at short term follow up (98.4%) and for EVLA at both mid and long term follow up (96.1% and 94.3%, respectively). Of the secondary outcomes, only major complications could be pooled. Deep venous thrombosis was found in 0.2% of all patients and nerve injury in 3.0%. Although risk of bias in the NMA was low, most network estimates were of low or very low GRADE quality. CONCLUSION: The limited number of high quality comparative studies on the SSV complicates ranking treatments based on anatomic success. However, RFA and EVLA showed the highest anatomic success.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Oud S, Alozai T, Jamaludin FS, et al. Anatomic Success of Treatment Modalities for Small Saphenous Vein Incompetence: A Systematic Review and Network Meta-analysis. Eur J Vasc Endovasc Surg. 2025. PMID: 40449724. doi:10.1016/j.ejvs.2025.05.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。